Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Apr;69(4):749–753. doi: 10.1038/bjc.1994.141

Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma.

Y Kakeji 1, Y Maehara 1, Y Adachi 1, H Baba 1, M Mori 1, M Furusawa 1, K Sugimachi 1
PMCID: PMC1968815  PMID: 7908217

Abstract

Proliferative activities in 181 primary Borrmann type 4 gastric carcinomas were investigated using percentage labelling of proliferating cell nuclear antigen (PCNA) and an argyrophilic nucleolar organiser region (AgNOR) count. Tumours with a high proliferative activity often metastasised to lymph nodes (P < 0.01), and these patients had a lower survival rate (P < 0.05). A significant correlation was recognised between the PCNA labelling percentage and AgNOR count (r = 0.452, P < 0.001). Cox's regression analysis showed that PCNA labelling percentage is an independent prognostic factor. These results indicate that estimating proliferative activity may be useful in predicting lymph node metastasis and patients' prognosis in cases of Borrmann type 4 gastric carcinoma.

Full text

PDF
749

Images in this article

750Figure 1
on p.750

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Borchard F. Classification of gastric carcinoma. Hepatogastroenterology. 1990 Apr;37(2):223–232. [PubMed] [Google Scholar]
  2. Bravo R., Frank R., Blundell P. A., Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987 Apr 2;326(6112):515–517. doi: 10.1038/326515a0. [DOI] [PubMed] [Google Scholar]
  3. Bravo R., Macdonald-Bravo H. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol. 1987 Oct;105(4):1549–1554. doi: 10.1083/jcb.105.4.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dimova R. N., Markov D. V., Gajdardjieva K. C., Dabeva M. D., Hadjiolov A. A. Electron microscopic localization of silver staining NOR-proteins in rat liver nucleoli upon D-galactosamine block of transcription. Eur J Cell Biol. 1982 Oct;28(2):272–277. [PubMed] [Google Scholar]
  5. Egan M. J., Crocker J. Nucleolar organiser regions in pathology. Br J Cancer. 1992 Jan;65(1):1–7. doi: 10.1038/bjc.1992.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fakan S., Hernandez-Verdun D. The nucleolus and the nucleolar organizer regions. Biol Cell. 1986;56(3):189–205. doi: 10.1111/j.1768-322x.1986.tb00452.x. [DOI] [PubMed] [Google Scholar]
  7. Furukawa H., Hiratsuka M., Iwanaga T. A rational technique for surgical operation on Borrmann type 4 gastric carcinoma: left upper abdominal evisceration plus Appleby's method. Br J Surg. 1988 Feb;75(2):116–119. doi: 10.1002/bjs.1800750209. [DOI] [PubMed] [Google Scholar]
  8. Iwanaga T., Furukawa H., Taniguchi H., Ishiguro S. [Extension modes in Borrmann-4 stomach carcinoma estimated by macroscopic appearances]. Gan No Rinsho. 1983 Feb;29(2):A-8, 120-4. [PubMed] [Google Scholar]
  9. Jaskulski D., deRiel J. K., Mercer W. E., Calabretta B., Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science. 1988 Jun 10;240(4858):1544–1546. doi: 10.1126/science.2897717. [DOI] [PubMed] [Google Scholar]
  10. Kakeji Y., Korenaga D., Tsujitani S., Haraguchi M., Maehara Y., Sugimachi K. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer. Cancer Res. 1991 Jul 1;51(13):3503–3506. [PubMed] [Google Scholar]
  11. Kamei H., Yamamura Y., Ichikawa K., Sugimoto K., Kojima T., Terabe K., Kondo T. Mitotic index in gastric carcinoma of the scirrhous type. Jpn J Surg. 1981;11(5):337–340. doi: 10.1007/BF02468957. [DOI] [PubMed] [Google Scholar]
  12. Kurki P., Lotz M., Ogata K., Tan E. M. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol. 1987 Jun 15;138(12):4114–4120. [PubMed] [Google Scholar]
  13. Maehara Y., Moriguchi S., Orita H., Kakeji Y., Haraguchi M., Korenaga D., Sugimachi K. Lower survival rate for patients with carcinoma of the stomach of Borrmann type IV after gastric resection. Surg Gynecol Obstet. 1992 Jul;175(1):13–16. [PubMed] [Google Scholar]
  14. McCormick D., Hall P. A. The complexities of proliferating cell nuclear antigen. Histopathology. 1992 Dec;21(6):591–594. doi: 10.1111/j.1365-2559.1992.tb00454.x. [DOI] [PubMed] [Google Scholar]
  15. Mori M., Kakeji Y., Adachi Y., Moriguchi S., Maehara Y., Sugimachi K., Jessup J. M., Chen L. B., Steele G. D., Jr The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer. Surgery. 1993 Jun;113(6):683–690. [PubMed] [Google Scholar]
  16. Nagayo T., Yokoyama H. Scirrhous carcinoma occurring in the corpus (body) of the stomach. Acta Pathol Jpn. 1974 Nov;24(6):797–814. doi: 10.1111/j.1440-1827.1974.tb00849.x. [DOI] [PubMed] [Google Scholar]
  17. Sowa M., Kato Y., Nishimura M., Yoshino H., Kubo T., Umeyama K. Clinico-histochemical studies on type 4 carcinoma of the stomach--with special reference to mucopolysaccharides and sialic acid in tumor tissue. Jpn J Surg. 1989 Mar;19(2):153–162. doi: 10.1007/BF02471579. [DOI] [PubMed] [Google Scholar]
  18. Sugano H., Nakamura K., Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32 (Suppl 2):329–347. [PubMed] [Google Scholar]
  19. Walker R. A. The histopathological evaluation of nucleolar organizer region proteins. Histopathology. 1988 Feb;12(2):221–223. doi: 10.1111/j.1365-2559.1988.tb01932.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES